TriSalus Life Sciences EPS - Earnings per Share 2021-2025 | TLSI
TriSalus Life Sciences eps - earnings per share from 2021 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| TriSalus Life Sciences Annual EPS | |
|---|---|
| 2024 | $-1.31 |
| 2023 | $-6.77 |
| 2022 | $-161.55 |
| 2021 | $0.15 |
| 2020 | $-0.12 |
| TriSalus Life Sciences Quarterly EPS | |
|---|---|
| 2025-09-30 | $-0.96 |
| 2025-06-30 | $-0.27 |
| 2025-03-31 | $-0.39 |
| 2024-12-31 | $-0.38 |
| 2024-09-30 | $-0.12 |
| 2024-06-30 | $-0.21 |
| 2024-03-31 | $-0.60 |
| 2023-12-31 | $29.78 |
| 2023-09-30 | $-0.14 |
| 2023-06-30 | $-35.84 |
| 2023-03-31 | $-0.57 |
| 2022-12-31 | $-135.77 |
| 2022-09-30 | $-25.95 |
| 2022-06-30 | $0.08 |
| 2022-03-31 | $0.09 |
| 2021-12-31 | $0.09 |
| 2021-09-30 | $0.06 |
| 2021-06-30 | $0.01 |
| 2021-03-31 | $-0.01 |
| 2020-12-31 | $0.00 |
| 2020-09-30 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.291B | $0.029B |
| TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.359B | 25.05 |
| EssilorLuxottica (ESLOY) | France | $151.069B | 0.00 |
| Boston Scientific (BSX) | United States | $138.964B | 31.78 |
| Stryker (SYK) | United States | $137.439B | 27.29 |
| Medtronic (MDT) | Ireland | $126.586B | 17.54 |
| Medline (MDLN) | United States | $57.028B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.992B | 0.00 |
| Agilent Technologies (A) | United States | $41.368B | 26.15 |
| GE HealthCare Technologies (GEHC) | United States | $38.856B | 18.58 |
| ResMed (RMD) | United States | $37.873B | 26.21 |
| Koninklijke Philips (PHG) | Netherlands | $28.984B | 18.93 |
| Terumo (TRUMY) | Japan | $21.172B | 23.83 |
| Insulet (PODD) | United States | $19.900B | 61.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.686B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.986B | 0.00 |
| Baxter (BAX) | United States | $10.199B | 8.23 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.585B | 30.87 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.350B | 13.25 |
| BillionToOne (BLLN) | United States | $4.319B | 0.00 |
| Envista Holdings (NVST) | United States | $3.979B | 22.83 |
| ICU Medical (ICUI) | United States | $3.666B | 23.28 |
| Haemonetics (HAE) | United States | $3.545B | 15.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.115B | 14.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.333B | 15.00 |
| Perrigo (PRGO) | Ireland | $2.045B | 5.12 |
| Neogen (NEOG) | United States | $2.043B | 44.71 |
| LeMaitre Vascular (LMAT) | United States | $1.939B | 39.02 |
| Curaleaf Holdings (CURLF) | Canada | $1.866B | 0.00 |
| AtriCure (ATRC) | United States | $1.858B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.734B | 76.00 |
| Phibro Animal Health (PAHC) | United States | $1.616B | 16.14 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.302B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.170B | 347.00 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.112B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| Omeros (OMER) | United States | $0.927B | 0.00 |
| Valneva SE (VALN) | France | $0.893B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.03 |
| CeriBell (CBLL) | United States | $0.851B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.573B | 15.55 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.483B | 0.00 |
| Brainsway (BWAY) | Israel | $0.461B | 78.50 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Quanterix (QTRX) | United States | $0.343B | 0.00 |
| Evolus (EOLS) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 22.06 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.206B | 0.00 |
| Accendra Health (ACH) | United States | $0.200B | 2.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 16.64 |
| Quipt Home Medical (QIPT) | United States | $0.159B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.77 |
| Exagen (XGN) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.76 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Nephros (NEPH) | United States | $0.047B | 33.92 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.74 |
| Jin Medical (ZJYL) | China | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |